Comments to FDA: Health Claims; Calcium, Vitamin D, and Osteoporosis

Share page:

Comments | Mar 14, 2007

Docket Number:
2004P-0464

CHPA Dietary Supplements Committee members fully support the proposed changes to the labeling requirements for health claims regarding calcium and osteoporosis. These proposed changes amend the regulation authorizing health claims on the relationship between calcium and a reduced risk of osteoporosis.

Related Posts

Press Releases and Statements

CHPA Welcomes Three Consumer Healthcare Industry Members

Press Releases and Statements

CHPA Statement Regarding ODSP Leadership

Press Releases and Statements

CHPA Applauds the Re-introduction of Bipartisan CBD Legislation